| Name | Idarucizumab |
|---|
| Description | Idarucizumab is a humanized monoclonal antibody fragment. Idarucizumab is first reversal agent for a direct oral anticoagulant (DOAC). Idarucizumab can specifically neutralize the effects of the oral direct thrombin inhibitor in order to restore hemostasis[1]. |
|---|---|
| Related Catalog | |
| References |
| No Any Chemical & Physical Properties |